Related Experiment Video
Updated: Jul 14, 2026

Continuous Telemetric In Utero Tracheal Pressure Measurements in Fetal Lambs
Published on: December 22, 2023
Mid-trimester amniocentesis and antibiotic prophylaxis
Dandolo Gramellini1, Stefania Fieni, Giovanna Casilla
1Department of Gynecology, Obstetrics and Neonatology, University of Parma, Parma, Italy. dandolo.gramellini@unipr.it
Objectives And Methods:
Assuming that the rate of fetal loss after amniocentesis may be reduced in patients receiving antibiotic prophylaxis, we conducted a retrospective study on untreated versus treated patients receiving prophylactic antibiotics (amoxicillin/clavulanic-acid or azithromycin) and evaluated the fetal loss rate within the 22nd week of gestation, also with respect to the risk of spontaneous abortion, both preexisting and related to mid-trimester amniocentesis.
Results:
Spontaneous abortion occurred in 22 cases out of 1744 (1.26%). The incidence of spontaneous abortion was 1.3% among patients treated with antibiotic prophylaxis and 1.2% among untreated patients. Between patients with risk factors that predated amniocentesis, the spontaneous fetal loss rate was 9.2% in untreated patients versus 2.3% in patients treated (p = 0.10). In patients with procedure-related risk factors at amniocentesis, the spontaneous abortion rate was, respectively, 2.2 and 1.2% (p = 0.72).
Conclusion:
Our data demonstrate that antibiotic prophylaxis does not reduce the risk of spontaneous abortion within the 22nd week of gestation. Compared with untreated patients, patients treated with amoxicillin showed the lower fetal loss rate (1.16 vs 0.31%), but the difference was not statistically significant (odds ratio (OR) = 3.68, p = 0.32). The same was true for patients with preexisting risks (OR = 4.25, p = 0.10).
More Related Videos
Related Concept Videos
Development of the Oral Microbiota
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Microbiota Modulation by Antibiotics
Acute Pyelonephritis II: Diagnostic Studies and Management
Development of Human Microbiota
Mechanism of Antibiotic Resistance in MRSA

